Low-dose dexamethasone suppression test in Dogs (Canis) | Vetlexicon
canis - Articles

Low-dose dexamethasone suppression test

ISSN 2398-2942


Synonym(s): LDDST

Overview

  • Administration of exogenous glucocorticoid (dexamethasone) suppresses hypothalamic-pituitary axis  .
  • Natural cortisol levels are suppressed for 78 h in normal animal.
  • Dogs with hyperadrenocorticism show breakthrough of suppression by 8 h.

Uses

In combination

  • In conjunction with clinical suspicion - diagnosis of hyperadrenocorticism (HAC) Hyperadrenocorticism.
  • Potentially able to differentiate between adrenal dependent HAC and pituitary dependent HAC.

Other points

  • The LDDST lacks specificity so its use is only recommended when there is strong clinical evidence to support a diagnosis of hyperadrenocorticism and other differentials for PUPD have been excluded. False positives are common with non-adrenal illness or stress.
  • Takes 8 h to complete.
  • Does not provide pre-treatment information for monitoring trilostane Trilostane therapy.
  • Cannot be used to diagnose hypoadrenocorticism Hypoadrenocorticism, iatrogenic hyperadrenocorticism or to monitor treatment of hyperadrenocorticism.
The test should not be performed on dogs that have recently received steroids.

Sampling

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Tests

Availability

  • Widely available at commercial laboratories.

Validity

Sensitivity

  • More reliable than ACTH stimulation test ACTH assay in confirming hyperadrenocorticism).
  • Overall sensitivity around 96.6%.
  • Lack of suppression at both 4 h and 8 h has the highest positive predictive vaule.
  • Escape or inverse patterns are associated with a lower positive predictive value.

Specificity

  • Specificity 67.2%.
  • More affected by non-adrenal disease than the ACTH stimulation test.
  • Specificity is poor in dogs with non-adrenal illness or concurrent diseases (especially diabetes melllitus Diabetes mellitus).
    Do not perform adrenal function tests in ill animals.
  • Only perform LDDST in animals where there is a strong indication to do so.

Technician extrinsic limitations

  • Must be able to give intravenous injection and collect samples without stressing animal.

Result Data

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from VetMedResource and PubMed.
  • Bannaim M, Shiel R E, Forde C & Mooney C T (2018) Evaluation of individual low dose dexamethasone test patterns in naturally occurring hyperadrenocorticism in dogs. JVIM 32(3), 967-977 PubMed.
  • Vaessen M M A R, Kooistra H S, Mol J A & Rijnberk A (2004) Urinary corticoid:creatinine ratios in healthy pet dogs after oral low-dose dexamethasone suppression testsVet Rec 155, 518-521.
  • Feldman E C, Nelson R W, Feldman M S (1996) Use of low- and high-dose dexamethasone suppression tests for distinguishing PDH from ADH in dogs. JAVMA 209, 772-775 PubMed.
  • Chauvet A E, Feldman E C, Kass P H (1995) Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. JAVMA 207, 1305-1307.
  • Kaplan A J, Peterson M E, Kemppainen R J (1995) Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. JAVMA 207, 445-451.

Other sources of information

  • Most commercial laboratories will provide information on test and interpretation of data.